Breast cancer cells with high ALDH1 activity also demonstrate stem cell properties, namely by contributing to metastases and chemotherapy resistance [12,13], as well as the ones co-expressing P-cadherin, CD44 and CD49f, especially in basal-like breast cancer [14,15]. Here, CD44 is linked to breast carcinoma.